Frazier Life Sciences Management, L.P. Iveric Bio, Inc. Transaction History

Frazier Life Sciences Management, L.P.

  • $1.9 Billion
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022
SELL
$9.12 - $18.9 $20.5 Million - $42.6 Million
-2,251,563 Reduced 92.98%
170,000 $1.64 Million
Q1 2022

May 16, 2022
BUY
$12.15 - $16.83 $29.4 Million - $40.8 Million
2,421,563 New
2,421,563 $40.8 Million

Others Institutions Holding ISEE

# of Institutions
7
Shares Held
250K
Call Options Held
40K
Put Options Held
0
View Full List

About IVERIC bio, Inc.

ISEE Quotes by TradingView
  • Ticker ISEE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,078,000
  • Description
  • IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...
More about ISEE
Track This Portfolio

Track Frazier Life Sciences Management, L.P. Portfolio

Follow Frazier Life Sciences Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frazier Life Sciences Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Frazier Life Sciences Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email